today announced an abstract on AFM24 dose optimization using exposure response analysis has been accepted for presentation as a poster at the Annual Meeting of the American Association for Cancer ...

TuHURA Biosciences, Inc.  ("TuHURA"), a Phase 3 immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today announced that an abstract highlighting ...

This abstract is a sub-study of the TIGeR-PaC clinical trial. The combination product candidate (IAG), which is enabled by the FDA-cleared RenovoCath device, is currently under investigation and ...

Holiday travel spa resort concept. Minimal abstract concrete texture background for cosmetic... Minimal abstract concrete texture background for cosmetic product presentation. Premium podium with ...

RenovoRx currently anticipates the completion of both patient enrollment and the second interim analysis for TIGeR-PaC in mid-2025. This abstract is a sub-study of the TIGeR-PaC clinical trial. The ...

MANNHEIM, Germany, March 25, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, ...

Bruce Nauman's celebrated Conceptual art ripened during the decade he worked in Pasadena. A fine gallery show assembles two ...

Senior Business Analyst Nastassia Shahun shares her insights as a judge and mentor at international hackathons — and why ...

Vice President Kashim Shettima has dismissed the belief in many quarters that federal structure is responsible for Nigeria’s ...

Virtual cryptocurrency workshop with expert Kamal Hubbard educates youth on digital finance as a potential solution to narrow ...

Abstract soft background. The concept of clean, beautiful, soft, shiny, simple, blurred motion design, vortex, business, finance, technology, future, game, internet ...